{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:05:04Z","timestamp":1791032704430,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/hjh.0b013e32832bd284","type":"journal-article","created":{"date-parts":[[2009,6,18]],"date-time":"2009-06-18T03:20:04Z","timestamp":1245295204000},"page":"1431-1438","source":"Crossref","is-referenced-by-count":7,"title":["Eplerenone does not attenuate diabetes-associated atherosclerosis"],"prefix":"10.1097","volume":"27","author":[{"given":"Philip JW","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Koitka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri J","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210208","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"R2-16-20210208","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.CIR.0000124061.78478.94","article-title":"Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis","volume":"109","author":"Candido","year":"2004","journal-title":"Circulation"},{"key":"R3-16-20210208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.hjh.0000191244.91314.9d","article-title":"Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes","volume":"24","author":"Burnier","year":"2006","journal-title":"J Hypertens"},{"key":"R4-16-20210208","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"R5-16-20210208","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R6-16-20210208","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R7-16-20210208","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00005344-200306000-00019","article-title":"Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice","volume":"41","author":"Keidar","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"R8-16-20210208","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","article-title":"Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts","volume":"4","author":"Park","year":"1998","journal-title":"Nat Med"},{"key":"R9-16-20210208","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/01.RES.0000266449.37396.1f","article-title":"Recipes for creating animal models of diabetic cardiovascular disease","volume":"100","author":"Hsueh","year":"2007","journal-title":"Circ Res"},{"key":"R10-16-20210208","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.CIR.0000021122.63813.32","article-title":"Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice","volume":"106","author":"Candido","year":"2002","journal-title":"Circulation"},{"key":"R11-16-20210208","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/jn\/123.11.1939","article-title":"AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet","volume":"123","author":"Reeves","year":"1993","journal-title":"J Nutr"},{"key":"R12-16-20210208","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/01.HYP.25.5.1111","article-title":"A noninvasive computerized tail-cuff system for measuring blood pressure in mice","volume":"25","author":"Krege","year":"1995","journal-title":"Hypertension"},{"key":"R13-16-20210208","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2006.11.021","article-title":"Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouse","volume":"195","author":"Calkin","year":"2007","journal-title":"Atherosclerosis"},{"key":"R14-16-20210208","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1161\/01.ATV.0000177813.99577.6b","article-title":"Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects","volume":"25","author":"Calkin","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R15-16-20210208","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2337\/db08-0057","article-title":"Oxidative stress as a major culprit in kidney disease in diabetes","volume":"57","author":"Forbes","year":"2008","journal-title":"Diabetes"},{"key":"R16-16-20210208","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"key":"R17-16-20210208","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/01.CIR.0000039325.03698.36","article-title":"RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice","volume":"106","author":"Bucciarelli","year":"2002","journal-title":"Circulation"},{"key":"R18-16-20210208","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1161\/CIRCULATIONAHA.106.664250","article-title":"Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice","volume":"115","author":"Lewis","year":"2007","journal-title":"Circulation"},{"key":"R19-16-20210208","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.ATV.0000204635.75748.0f","article-title":"Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation","volume":"26","author":"Suzuki","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R20-16-20210208","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000015854.60710.10","article-title":"Mineralocorticoid receptor antagonism in experimental atherosclerosis","volume":"105","author":"Rajagopalan","year":"2002","journal-title":"Circulation"},{"key":"R21-16-20210208","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/ATVBAHA.107.144824","article-title":"Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease","volume":"27","author":"Scatena","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R22-16-20210208","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/13813450601094672","article-title":"Monocyte chemoattractant protein-1: a major contributor to the inflammatory process associated with diabetes","volume":"112","author":"Dragomir","year":"2006","journal-title":"Arch Physiol Biochem"},{"key":"R23-16-20210208","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.0000127949.05756.9D","article-title":"Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone","volume":"109","author":"Keidar","year":"2004","journal-title":"Circulation"},{"key":"R24-16-20210208","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1291\/hypres.31.363","article-title":"Aldosterone nongenomically produces NADPH oxidase-dependent reactive oxygen species and induces myocyte apoptosis","volume":"31","author":"Hayashi","year":"2008","journal-title":"Hypertens Res"},{"key":"R25-16-20210208","doi-asserted-by":"crossref","first-page":"F723","DOI":"10.1152\/ajprenal.00480.2006","article-title":"Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin","volume":"293","author":"Zhang","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R26-16-20210208","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1681\/ASN.2005040390","article-title":"Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells","volume":"16","author":"Miyata","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R27-16-20210208","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.hdx.0000089783.30450.cb","article-title":"Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure","volume":"5","author":"Moore","year":"2003","journal-title":"Heart Dis"},{"key":"R28-16-20210208","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1071-9164(03)00578-5","article-title":"Role of a selective aldosterone blocker in mice with chronic heart failure","volume":"10","author":"Wang","year":"2004","journal-title":"J Card Fail"},{"key":"R29-16-20210208","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3317\/jraas.2006.002","article-title":"Aldosterone blockade over and above ACE-inhibitors in patients with coronary artery disease but without heart failure","volume":"7","author":"Shah","year":"2006","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R30-16-20210208","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.HYP.0000157408.43807.5a","article-title":"Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway","volume":"45","author":"Kobayashi","year":"2005","journal-title":"Hypertension"},{"key":"R31-16-20210208","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.metabol.2006.07.025","article-title":"The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy","volume":"55","author":"Matsumoto","year":"2006","journal-title":"Metabolism"},{"key":"R32-16-20210208","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s00125-004-1510-8","article-title":"Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes","volume":"47","author":"Davies","year":"2004","journal-title":"Diabetologia"},{"key":"R33-16-20210208","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/path.2357","article-title":"Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions","volume":"215","author":"Sluimer","year":"2008","journal-title":"J Pathol"},{"key":"R34-16-20210208","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1440-1681.2008.04883.x","article-title":"Vascular angiotensin AT2 receptors in hypertension and ageing","volume":"35","author":"Widdop","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R35-16-20210208","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1210\/jc.2007-0393","article-title":"Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus","volume":"92","author":"Joffe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-16-20210208","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"R37-16-20210208","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/ndt\/gfn448","article-title":"Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats","volume":"24","author":"Kang","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R38-16-20210208","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1463-1326.2007.00730.x","article-title":"Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS","volume":"10","author":"O'Keefe","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"R39-16-20210208","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1345\/aph.1E306","article-title":"Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure","volume":"39","author":"Barnes","year":"2005","journal-title":"Ann Pharmacother"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004872-200907000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:50:55Z","timestamp":1786038655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-200907000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e32832bd284","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}